NRXS
Price:
$2.71
Market Cap:
$28.86M
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
Industry
Biotechnology
IPO Date
2023-08-09
Stock Exchange
NASDAQ
Ticker
NRXS
According to NeurAxis, Inc.’s latest financial reports and current stock price. The company's current ROE is -340.23%. This represents a change of 25.52% compared to the average of -271.06% of the last 4 quarters.
The mean historical ROE of NeurAxis, Inc. over the last ten years is 173.92%. The current -340.23% ROE has changed -295.62% with respect to the historical average. Over the past ten years (40 quarters), NRXS's ROE was at its highest in in the September 2023 quarter at 462.20%. The ROE was at its lowest in in the March 2025 quarter at -881.57%.
Average
173.92%
Median
85.76%
Minimum
-398.57%
Maximum
1.04%
Discovering the peaks and valleys of NeurAxis, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.12%
Maximum Annual ROE = 1.04%
Minimum Annual Increase = -261.78%
Minimum Annual ROE = -398.57%
| Year | ROE | Change |
|---|---|---|
| 2024 | -398.57% | -138.24% |
| 2023 | 1.04% | 1.12% |
| 2022 | 85.76% | -76.61% |
| 2021 | 366.74% | -261.78% |
The current ROE of NeurAxis, Inc. (NRXS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
243.18%
5-year avg
173.92%
10-year avg
173.92%
NeurAxis, Inc.’s ROE is greater than CollPlant Biotechnologies Ltd. (-102.03%), less than NeuroSense Therapeutics Ltd. (2.72%), greater than Exicure, Inc. (-110.40%), greater than Klotho Neurosciences, Inc. (-201.59%), greater than Enlivex Therapeutics Ltd. (-62.91%), greater than Cadrenal Therapeutics, Inc. Common Stock (-279.52%), greater than Sonnet BioTherapeutics Holdings, Inc. (-4648.06%), less than Minerva Neurosciences, Inc. (-0.00%), greater than TAO Synergies Inc. (-256.58%), greater than Rallybio Corporation (-71.66%),
| Company | ROE | Market cap |
|---|---|---|
| -102.03% | $26.70M | |
| 2.72% | $29.60M | |
| -110.40% | $42.96M | |
| -201.59% | $25.82M | |
| -62.91% | $28.19M | |
| -279.52% | $23.04M | |
| -4648.06% | $8.43M | |
| -0.00% | $26.16M | |
| -256.58% | $23.26M | |
| -71.66% | $28.16M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeurAxis, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NeurAxis, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is NeurAxis, Inc.'s ROE?
How is the ROE calculated for NeurAxis, Inc. (NRXS)?
What is the highest ROE for NeurAxis, Inc. (NRXS)?
What is the 3-year average ROE for NeurAxis, Inc. (NRXS)?
What is the 5-year average ROE for NeurAxis, Inc. (NRXS)?
How does the current ROE for NeurAxis, Inc. (NRXS) compare to its historical average?